Projects per year
Personal profile
Fingerprint
- 1 Similar Profiles
Most recent collaborations and top research areas
-
CDL: Jost: Christian Doppler (CD) Laboratory for Activation of Immunogenic Cell Death in Lung Cancer
Jost, P. (Principal investigator)
1/01/26 → 31/12/27
Project: Research funding
-
EUnetCCC: EUnetCCC
Jost, P. (Principal investigator), Kienreich, S. M. (Co-investigator), Schernthanner, L. (Co-investigator), Jonsson, G. (Co-investigator) & Flasch, B. (Co-investigator)
1/10/24 → 30/09/28
Project: Research funding
-
ZAP Cancer: TWINNING FOR EXCELLENCE TO ADVANCE RESEARCH IN THE ACTIVATION OF ANTI-TUMOR IMMUNE RESPONSE AFTER ELECTROCHEMOTHERAPY COMBINED WITH GENE ELETROTRANSFER OF pDNA ENCODING ICIs
Jost, P. (Principal investigator)
1/10/24 → 30/09/27
Project: Research funding
-
TARGET MPN: TARgetinG disease pErsisTence and progression of MyeloProliferative Neoplasms
Jost, P. (Principal investigator)
1/06/24 → 10/07/28
Project: Research funding
-
Deciphering the role of necroptosis-induced inflammation in lung adenocarcinomas
Jost, P. (Principal investigator)
1/01/24 → 22/12/27
Project: Research funding
-
Aberrant methylation limits antitumoral inflammation in lung adenocarcinoma by restricting RIPK3 expression.
Agrawal, D., Vizar Cisarova, K. (First author), Vosberg, S., Allmendinger, F., Munkhbaatar, E., Dandachi, N., Fernandez Hernandez, F. J., Tonietto, M., Jäger, V., Anton, M., Keller, E., Jesinghaus, M., Meinhardt, A., Haefner, V., Stoeger, T., Steiger, K., McGranahan, N., Dengler, M., Wahida, A. & Jost, P., 23 Jan 2026, In: Science Advances. 12, 4, p. eadz9227 13 p., eadz9227.Research output: Contribution to journal › Research article
1 Citation (Web of Science) -
Cell death in cancer
Conrad, M., Strasser, A., Jost, P., Yuan, J., Shao, F., Vandenabeele, P. & Wahida, A., 16 Apr 2026, In: Cell. 189, p. 2322-2356 35 p.Research output: Contribution to journal › Review
4 Citations (Web of Science) -
Clinical outcomes of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil or regorafenib in metastatic colorectal cancer: a multicenter cohort study.
Moik, F. (First author), Huemer, F., Doleschal, B., Taghizadeh, H., Reimann, P., Kostmann, S. M., Wagner, L., Abdel, H., Zimmer, K., Suppé, S., Bachleitner, C., Schaberl-Moser, R., Amann, A., Wolf, D., Greil, R., Jost, P., Winder, T., Rumpold, H., Weiss, L. & Gerger, A. & 2 others, , Apr 2026, In: ESMO Open. 11, 4, p. 106907 10 p., 106907.Research output: Contribution to journal › Research article
-
Early Detection of Cell Death Using Transmembrane Water Exchange Magnetic Resonance Imaging.
Kaika, A., Nagel, L., Höckendorf, U., Xie, B., Topping, G., Schillmaier, M., Beer, I., van Heijster, F., Rauch, J., Kuder, T., Sühnel, S., Erber, B., Lohrmann, C., Ballke, S., Metzler, T., Steiger, K., Jost, P., Ivleva, N., Paprottka, P. & Nadjiri, J. & 3 others, , Apr 2026, In: Advanced Science. 13, 23, p. e13317 14 p.Research output: Contribution to journal › Research article
-
Integrating baseline ctDNA-derived tumor metrics enhances risk stratification in HR-positive/HER2-negative advanced breast cancer: a real-world multicenter cohort study from Austria
Dobric, N. (First author), Hasenleithner, S., Suppan, C., Klocker, E. V., Hlauschek, D., Graf, R., Beichler, C., Albertini, C., Egle, D., Liu, D., Starzer, A., Bartsch, R., Moser, T., Rinnerthaler, G., Jost, P., Heitzer, E., Dandachi, N. & Balic, M., Apr 2026, In: ESMO Open. 11, 4, p. 106939 12 p., 106939.Research output: Contribution to journal › Research article
-
Circulating tumor DNA profiling of patients with metastatic luminal HER2-low and HER2-0 breast cancer via next-generation sequencing.
Dobri, N. (Author), Dandachi, N. (Author), Klocker, E. V. (Author), Suppan, C. (Author), Graf, R. (Author), Lazzeri, I. (Author), Albertini, C. (Author), Rinnerthaler, G. (Author), Starzer, A. (Author), Bartsch, R. (Author), Hasenleithner, S. (Author), Jost, P. (Author), Heitzer, E. (Author) & Balic, M. (Author)
2025Activity: Talk, presentation or poster › Poster
-
Prognostic impact of targetable driver alterations in resected early-stage lung cancer
John, N. (Author), Terbuch, A. (Author), Konjic, S. (Author), Absenger, G. (Author), Jost, P. (Author), Lindenmann, J. (Author), Fediuk, M. (Author), John, T. (Author), Wurm, R. (Author), Zacharias, M. (Author), Posch, F. (Author), Hochmaier, M. (Author), Fabikan, H. (Author), Weinlinger, C. (Author), Illini, O. (Author), Horvath, L. (Author), Gamerith, G. (Author), Pircher, A. (Author) & Brcic, L. (Author)
2024Activity: Talk, presentation or poster › Poster
-
A head-to-head comparison for detecting PIK3CA mutations in circulating tumor DNA of advanced HR+/HER2-breast cancer patients
Dandachi, N. (Author), Graf, R. (Author), Pancheri, L. (Author), Dobric, N. (Author), Klocker, E. V. (Author), Suppan, C. (Author), Jost, P. (Author), Heitzer, E. (Author) & Balic, M. (Author)
2023Activity: Talk, presentation or poster › Poster
-
Comparison of ctDNA profiles from HR+/HER2-low and HR+/HER2-0 advanced breast cancer patients
Dobric, N. (Author), Dandachi, N. (Author), Klocker, E. V. (Author), Suppan, C. (Author), Graf, R. (Author), Hasenleithner, S. (Author), Jost, P. (Author), Heitzer, E. (Author) & Balic, M. (Author)
2023Activity: Talk, presentation or poster › Poster
-
SOUND: A phase II trial evaluating the efficacy of molecular profiling of circulating ± tumor tissue DNA for salvagetherapy matching in patients with advanced and refractory carcinoma
Riedl, J. (Author), Steinlechner, S. (Author), Moik, F. (Author), Heitzer, E. (Author), Jahn, S. (Author), Hasenleithner, S. (Author), Doleschal, B. (Author), Weiss, L. (Author), Seeber, A. (Author), Rumpold, H. (Author), Winder, T. (Author), Greil, R. (Author), Jost, P. (Author), Höfler, G. (Author), Speicher, M. (Author) & Gerger, A. (Author)
2023Activity: Talk, presentation or poster › Poster